Escre suppositories for hypnosis and sedation (chloral hydrate)

Are Escre suppositories effective for hypnosis and sedation (chloral hydrate)?

Escre suppositories with chloral hydrate are a specialized pharmaceutical formulation intended for sedation and hypnosis at laboratory tests (such as electroencephalography, electrocardiography and electromyography) and for treatment of convulsion difficult for treatment with intravenous injection. Chloral hydrate has been used in clinical medicine since the 19th century and remains relevant today due to pharmacological properties that are not fully replicated by many modern oral sedatives.

Pharmacological Characteristics of Chloral Hydrate

Chloral hydrate acts as a central nervous system depressant with sedative, hypnotic, and anticonvulsive effects. After administration, it is metabolized in vivo to trichloroethanol, which mediates its primary pharmacological activity through modulation of the GABA receptor complex.

A defining feature of chloral hydrate is its limited suppression of epileptiform discharges. While many contemporary sedatives effectively induce sleep or calmness, they may interfere with cortical electrical activity, making them unsuitable for certain neurological examinations. Chloral hydrate retains diagnostic signal clarity while providing adequate sedation.

Specific Clinical Uses of Escre Suppositories

Escre suppositories are primarily used in controlled medical settings where alternative sedatives may compromise diagnostic accuracy or cannot be administered effectively. Their role is focused and well established.

Common clinical applications include

• Sedation and hypnosis prior to electroencephalography, where preservation of epileptiform activity is critical
• Use during electrocardiography and electromyography when patient immobility is required without deep cortical suppression
• Management of convulsive conditions that are difficult to treat via intravenous injection
• Situations where oral administration is unsuitable or unreliable

These sedation suppositories are selected based on pharmacological suitability rather than convenience, reflecting their purpose-driven use.

Why Chloral Hydrate Remains Clinically Relevant

Although modern medicine offers a wide range of oral sedatives for insomnia and general anxiety, chloral hydrate continues to occupy a specific therapeutic niche. Its predictable metabolism, long clinical history, and minimal interference with neurological diagnostic signals distinguish it from newer agents.

Escre chloral hydrate suppositories are therefore used not as a first-line sedative, but as a deliberate choice in cases where diagnostic integrity or route of administration is a priority.

Focused Sedation with Established Clinical Rationale

Escre suppositories with chloral hydrate exemplify a medication retained in practice due to clearly defined advantages in specialized contexts. For healthcare professionals and institutions seeking sedation suppositories suited to neurological diagnostics or complex convulsive cases, chloral hydrate remains a recognized option.

Package details: 30 pcs

Dosage and administration: for children, insert 30 to 50 mg of the active ingredient per kg of the body weight into rectum at a time. Your doctor may adjust the dosage according to the age, symptoms or purpose. The maximum total dose is up to 1.5 g.

Please note that this medicine contains 500 mg of the active ingredient in one suppository.

Active components: chloral hydrate

Therapeutic effect: sedation and hypnosis at laboratory tests (such as electroencephalography, electrocardiography and electromyography) and for treatment of convulsion difficult for treatment with intravenous injection

Contraindications and precautions: Store in a dry cool place, out of reach of children. Do not use for pregnant or breastfeeding women. Do not use for patients with a history of gelatin allergy. Do not use for patients with an have acute intermittent porphyria. Do not expose to sunlight or heat. If allergic symptoms occur, discontinue use.